PAVmed (PAVM) Enterprise Value (2015 - 2025)

PAVmed's Enterprise Value history runs 11 years deep, the most recent figure standing at -$13.2 million for Q4 2025.

• In Q4 2025, Enterprise Value fell 118.65% year-over-year to -$13.2 million; the TTM figure through Dec 2025 stood at -$13.2 million (down 118.65% YoY), while the FY2025 annual figure was -$13.2 million, down 118.65% from the prior year.
• Enterprise Value was -$13.2 million for Q4 2025 at PAVmed, up from -$13.4 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of $39.9 million in Q3 2024 to a low of -$59.5 million in Q4 2021.
• Historically, Enterprise Value has averaged -$15.7 million across 5 years, with a median of -$13.5 million in 2025.
• The sharpest annual moves came in 2021 and 2024: Enterprise Value plunged 415.13% in 2021, then surged 559.87% in 2024.
• A 5-year view of Enterprise Value shows it stood at -$59.5 million in 2021, then surged by 67.85% to -$19.1 million in 2022, then jumped by 153.19% to $10.2 million in 2023, then plunged by 159.19% to -$6.0 million in 2024, then plunged by 118.65% to -$13.2 million in 2025.
• The last three Enterprise Value figures came in at -$13.2 million (Q4 2025), -$13.4 million (Q3 2025), and -$13.7 million (Q2 2025), per Business Quant data.